|Bid||71.12 x 1000|
|Ask||71.74 x 44000|
|Day's Range||81.53 - 82.42|
|52 Week Range||66.72 - 92.97|
|PE Ratio (TTM)||11.39|
|Dividend & Yield||3.30 (3.39%)|
|1y Target Est||N/A|
Sanofi Pasteur, Sanofi’s (SNY) human vaccine business, reported 26.2% revenue growth at constant exchange rates to 1.0 billion euros in 2Q17. Sanofi Pasteur reported growth across all product franchises ...
Sanofi’s (SNY) generic business contributed ~5.1% of its total revenue in 2Q17. The business reported revenue of 442 million euros in 2Q17, an 8% decrease from 2Q16. Revenue fell due…
Sanofi’s (SNY) established products contributed over 29.5% of its total revenue in 2Q17. Established product revenue, which fell 2.3% at constant exchange rates in 2Q17, stood at 2.6 billion euros. Lower…...